LIF and pulmonary arterial hypertension: The results revealed significantly elevated Factor D levels in SSc-PAH patients (2.3 μg/mL) compared to healthy controls (0.9 μg/mL, p < 0.0001) and SSc patients without PAH (2.1 μg/mL, p < 0.0001).